Burosumab-twza Subcutaneous and Metoprolol Extended-Release Capsules
Determining the interaction of Burosumab-twza Subcutaneous and Metoprolol Extended-Release Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: burosumab
Brand name: Crysvita
Synonyms: Burosumab
Generic Name: metoprolol
Brand name: Kapspargo Sprinkle, Lopressor, Toprol-XL, Toprol XL
Synonyms: Metoprolol
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Burosumab-twza Subcutaneous-Metoprolol Extended-Release Tablets
- Burosumab-twza Subcutaneous-Metoprolol Injection
- Burosumab-twza Subcutaneous-Metoprolol Intravenous
- Burosumab-twza Subcutaneous-Metoprolol Succinate
- Burosumab-twza Subcutaneous-Metoprolol Succinate ER Capsules
- Burosumab-twza Subcutaneous-Metoprolol Succinate ER Tablets
- Metoprolol Extended-Release Capsules-Buspar
- Metoprolol Extended-Release Capsules-Buspar Dividose
- Metoprolol Extended-Release Capsules-Buspirone
- Metoprolol Extended-Release Capsules-Buspirone Hydrochloride
- Metoprolol Extended-Release Capsules-Busulfan
- Metoprolol Extended-Release Capsules-Busulfan Concentrate Injection